Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

2.0K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.5K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Stem Cell Niche01:26

Stem Cell Niche

6.1K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanozymes for Bone Regeneration: Mechanistic Insights into Immune and Metabolic Microenvironment Modulation.

International journal of nanomedicine·2026
Same author

Impact of Early Surgery on Clinical Outcomes of Super-Aged Patients With Hip Fractures: A Retrospective Propensity Score-Matched Study With 2-Year Follow-Up.

Orthopaedic surgery·2026
Same author

Gut-Bone Axis Mediates Exercise Modality-Dependent Suppression of Inflammatory Osteoclastogenesis in Ovariectomy-Induced Bone Loss.

Mediators of inflammation·2026
Same author

Preoperative Indicators for 1-year Mortality in Elderly Individuals Following Hip Fracture Surgery Under A Multidisciplinary Team Co-Management Model: A Single-Centre Retrospective Observational Study.

Geriatric orthopaedic surgery & rehabilitation·2025
Same author

Geriatric Nutritional Risk Index and Prognostic Nutritional Index as Predictors of One-Year Mortality in Older Patients After Hip Fracture Surgery: A Retrospective Cohort Study.

Geriatric orthopaedic surgery & rehabilitation·2025
Same author

Nanoparticle-Driven Tendon Repair: Role of Vasoactive Intestinal Peptide in Immune Modulation and Stem Cell Enhancement.

ACS nano·2025

Related Experiment Video

Updated: Jan 2, 2026

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms
08:32

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms

Published on: March 22, 2024

1.6K

CTGF Attenuates Tendon-Derived Stem/Progenitor Cell Aging.

Yun-Feng Rui1,2,3,4,5, Min-Hao Chen1,2,3,4,5, Ying-Juan Li5,6

  • 1Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.

Stem Cells International
|December 13, 2019
PubMed
Summary
This summary is machine-generated.

Connective tissue growth factor (CTGF) declines in aged tendon stem cells, impairing healing. Supplementing CTGF rejuvenates these cells, offering a potential therapy for age-related tendon disorders.

More Related Videos

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
04:48

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair

Published on: March 1, 2024

2.3K
A Protocol to Acquire the Degenerative Tenocyte from Humans
09:25

A Protocol to Acquire the Degenerative Tenocyte from Humans

Published on: June 9, 2018

7.7K

Related Experiment Videos

Last Updated: Jan 2, 2026

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms
08:32

Author Spotlight: Advancing Tendon Research by Developing Mouse Assembloids to Understand Cellular Mechanisms

Published on: March 22, 2024

1.6K
Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair
04:48

Author Spotlight: Advancements in Cell and Tissue Engineering for Tendon Repair

Published on: March 1, 2024

2.3K
A Protocol to Acquire the Degenerative Tenocyte from Humans
09:25

A Protocol to Acquire the Degenerative Tenocyte from Humans

Published on: June 9, 2018

7.7K

Area of Science:

  • Biogerontology
  • Stem Cell Biology
  • Musculoskeletal Research

Background:

  • Aged tendon-derived stem/progenitor cells (TSPCs) contribute to age-related tendon disorders and impaired healing.
  • The molecular mechanisms driving TSPC aging are not well understood.

Purpose of the Study:

  • To investigate the role of connective tissue growth factor (CTGF) in the aging process of TSPCs.
  • To explore CTGF as a potential therapeutic target for age-related tendon conditions.

Main Methods:

  • Quantification of CTGF protein and mRNA levels in aged TSPCs.
  • Treatment of aged TSPCs with recombinant CTGF.
  • Analysis of TSPC self-renewal, differentiation, and cell cycle progression.
  • Assessment of cell cycle regulatory proteins (cyclin D1, CDK4, p27kip1).

Main Results:

  • CTGF levels were significantly decreased in aged TSPCs.
  • Recombinant CTGF treatment attenuated TSPC aging, restoring self-renewal and differentiation.
  • CTGF promoted G1/S phase transition in aged TSPCs arrested in G1/S.
  • CTGF treatment normalized cyclin D1 and CDK4 levels while reducing p27kip1 expression.

Conclusions:

  • CTGF plays a critical role in TSPC aging.
  • CTGF may serve as a potential molecular therapeutic target for age-related tendon disorders and impaired tendon healing.